Inhibition of leukotriene production by FK506 in rat basophilic leukemia-1 cells

Pharmacology. 1995 Mar;50(3):137-45. doi: 10.1159/000139275.

Abstract

We investigated the inhibitory action of FK506 (0.0005-5 micrograms/ml) on the metabolism of arachidonate 5-lipoxygenase in rat basophilic leukemia-1 cells. Cells were stimulated with A23187 (10(-5) mol/l) for 15 min in the absence or presence of various concentrations of FK506. Arachidonate 5-lipoxygenase metabolites, peptide leukotrienes (LTs), leukotriene B4 (LTB4) and 5-hydroxyeicosatetraenoic acid (5-HETE) were measured by high-performance liquid chromatography. FK506 inhibited A23187-stimulated production of peptide LTs, LTB4 and 5-HETE in intact cells by up to 77, 73 and 60%, respectively. Phospholipase A2 activity, measured by the release of 3H-arachidonic acid (AA), was not significantly inhibited by FK506. The synthesis of peptide LTs and LTB4 was not inhibited by FK506 when leukotriene A4-free acid was added to the culture medium. The synthesis of peptide LTs, LTB4 and 5-HETE was not affected by FK506 in a cell lysate study using AA as the substrate. These results indicate that FK506 inhibits the production of peptide LTs, LTB4 and 5-HETE by inhibiting 5-lipoxygenase activity in intact cells. The inhibition is not a direct action on 5-lipoxygenase but results from the activating processes of this enzyme.

MeSH terms

  • Animals
  • Hydroxyeicosatetraenoic Acids / biosynthesis*
  • Leukemia, Basophilic, Acute
  • Leukotrienes / biosynthesis*
  • Lipoxygenase Inhibitors*
  • Phospholipases A / metabolism
  • Phospholipases A2
  • Rats
  • Tacrolimus / pharmacology*
  • Tumor Cells, Cultured

Substances

  • Hydroxyeicosatetraenoic Acids
  • Leukotrienes
  • Lipoxygenase Inhibitors
  • 5-hydroxy-6,8,11,14-eicosatetraenoic acid
  • Phospholipases A
  • Phospholipases A2
  • Tacrolimus